Skip to main content
Clinical Trials/NCT04551105
NCT04551105CompletedNot Applicable

Evaluation of TaiHao Breast Ultrasound Diagnosis Software

TaiHao Medical Inc.1 site in 1 country16 target enrollmentStarted: August 15, 2020Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
16
Locations
1
Primary Endpoint
Comparing the Area Under the LROC Curve

Study Overview

Brief Summary

The BR-USCAD DS Module is a computer-assisted detection and diagnosis software based on a deep learning algorithm. This retrospective, fully-crossed, multi-reader, multi-case (MRMC) study aims to compare the performances of readers without and with the aid of the Breast Ultrasound Image Reviewed with Assistance of Computer-Assisted Detection and Diagnosis System (BR-USCAD DS) in interpreting breast ultrasound images of lesions.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Crossover
Primary Purpose
Diagnostic
Masking
None

Eligibility Criteria

Ages
21 Years to — (Adult, Older Adult)
Sex
Female
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •B-mode breast ultrasound image
  • •Female, age 21 or older
  • •Breast lesion images acquired before a biopsy or surgery - these images were retrospectively collected with histology report.
  • •Non-biopsied benign lesions with negative follow-up for a minimum of 24 months
  • •At least two orthogonal views of a lesion

Exclusion Criteria

  • •Breast lesion images acquired after biopsy or surgery.
  • •Any breast surgeries or interventional procedures in the 12 months prior to ultrasound imaging
  • •Case demonstrating administrative or technical errors
  • •Multiple lesions in one 2-D ultrasound image
  • •Breast ultrasound images with Doppler, elastography, or other overlays present
  • •Case with less than 2-year follow-up and without biopsy confirmation

Arms & Interventions

First session: manual review first and then review with CADx

Active Comparator

Reader Group X interpret the "Dataset A" cases in different random order without any assistance of AI first, and then interpret the "Dataset B" cases in different random order with TaiHao AI system.

Intervention: Reader Group X - Session 1 (Diagnostic Test)

First session: review with CADx first and then manual review

Active Comparator

Reader Group Y interpret the "Dataset A" cases in different random order with TaiHao AI system first, and then interpret the "Dataset B" cases in different random order without any assistance of AI.

Intervention: Reader Group Y - Session 1 (Diagnostic Test)

Second session: manual review first and then review with CADx

Active Comparator

At least 4 weeks after first session for memory washing out. Reader Group X interpret the "Dataset A" cases in different random order with TaiHao AI system first, and then interpret the "Dataset B" cases in different random order without any assistance of AI.

Intervention: Reader Group X - Session 2 (Diagnostic Test)

Second session: review with CADx first and then manual review

Active Comparator

At least 4 weeks after first session for memory washing out. Rader Group Y interpret the "Dataset A" cases in different random order without any assistance of AI first, and then interpret the "Dataset B" cases in different random order with TaiHao AI system.

Intervention: Reader Group Y - Session 2 (Diagnostic Test)

Outcomes

Primary Outcomes

Comparing the Area Under the LROC Curve

Time Frame: 10 weeks

The area under the LROC curve (AUC_LROC) on the diagnosis of benign and malignant lesions was computed and compared for Aim 1 (baseline) and Arm 2 (with BU-CAD assistance) studies.

Secondary Outcomes

  • The Sensitivity, Specificity, PPV, and NPV Were Computed and Compared for Aim 1 (Baseline) and Arm 2 (With BU-CAD Assistance) Studies.(10 weeks)
  • The Reading Time Was Computed and Compared for Aim 1 (Baseline) and Arm 2 (With BU-CAD Assistance) Studies.(10 weeks)

Investigators

Sponsor Class
Industry
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials